We summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreWhen making a decision about the approval of a new product NICE (National Institute for Health and C...
Read moreThe Head of Agency Group (HAG) is a recently launched network created by the European Health Technol...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read moreThe use of combination therapy is increasingly becoming the standard of care in oncology as cancers ...
Read moreThe IHSI is an independent legal entity, with representatives from eight member countries.
Read moreIn oncology, a hazard ratio (HR) is commonly used to estimate the treatment effect for survival endp...
Read moreThe QALY Shortfall aims to capture and recognise disease severity by assessing the degree of quality...
Read moreWe summarise key pharmaceutical, pricing and market access insights that are worth reading about thi...
Read more